TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Astimex Pharma AB
Closing information (x1000 EUR)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
6,443
|
4,532
|
3,739 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
2,932
|
1,633
|
1,054 |
| EBITDA |
2,809
|
1,581
|
1,060 |
| Total assets |
4,629
|
5,533
|
4,955 |
| Current assets |
4,618
|
5,510
|
4,936 |
| Current liabilities |
971
|
666
|
722 |
| Equity capital |
3,371
|
4,590
|
4,030 |
| - share capital |
9
|
8
|
9 |
| Employees (average) |
6
|
6
|
6 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
72.8%
|
83.0%
|
81.3% |
| Turnover per employee |
1,074
|
755
|
623 |
| Profit as a percentage of turnover |
45.5%
|
36.0%
|
28.2% |
| Return on assets (ROA) |
63.3%
|
29.5%
|
21.3% |
| Current ratio |
475.6%
|
827.3%
|
683.7% |
| Return on equity (ROE) |
87.0%
|
35.6%
|
26.2% |
| Change turnover |
1,738
|
1,146
|
144 |
| Change turnover % |
37%
|
34%
|
4% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.